In conclusion, targeting SIRT3 emerges as a promising therapeutic approach in pancreatic cancer, given its multifaceted role in regulating mitochondrial metabolism, oxidative stress and key oncogenic pathways. This evidence concerns the gene SIRT3 and familial pancreatic carcinoma.